Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
| $39M | 0.01% |
1,471,732
+857,013
| +139% | +$28M |
|
902
Incyte
INCY
$24.5B
| $38.7M | 0.01% |
391,819
-96,312
| -20% | -$9.32M |
|
903
STMicroelectronics
STM
$49.2B
| $38.7M | 0.01% |
1,490,731
+268,849
| +22% | +$6.9M |
|
904
PUT
DraftKings
DKNG
$12.5B
| $38.4M | 0.01% |
1,115,000
-223,400
| -17% | -$7.35M |
|
|
GAP
905
CALL
The Gap Inc
GAP
$7.55B
| $38.4M | 0.01% |
1,500,100
+442,500
| +42% | +$10.7M |
|
|
JBTM
906
JBT Marel
JBTM
$6.34B
| $38.4M | 0.01% |
254,762
+14,416
| +6% | +$2.03M |
|
907
CALL
Boyd Gaming
BYD
$6.04B
| $38.4M | 0.01% |
450,000
| – | – |
|
|
RNAM
908
DELISTED
Avidity Biosciences
RNAM
| $38.3M | 0.01% |
531,203
+178,916
| +51% | +$11.6M |
|
909
Regal Rexnord
RRX
$11.6B
| $38.3M | 0.01% |
272,904
-59,935
| -18% | -$8.53M |
|
910
CALL
First Horizon
FHN
$12B
| $38.2M | 0.01% |
+1,600,000
| New | +$35.7M |
|
|
911
CALL
DraftKings
DKNG
$12.5B
| $38M | 0.01% |
1,102,900
+374,600
| +51% | +$12.3M |
|
912
Rivian
RIVN
$23.5B
| $38M | 0.01% |
1,926,546
-230,694
| -11% | -$3.66M |
|
913
Upstart Holdings
UPST
$2.85B
| $37.8M | 0.01% |
864,102
+144,692
| +20% | +$6.66M |
|
|
CRCL
914
Circle Internet Group
CRCL
$17.9B
| $37.7M | 0.01% |
475,710
+324,342
| +214% | +$33.5M |
|
915
Deckers Outdoor
DECK
$12.8B
| $37.7M | 0.01% |
363,176
-304,983
| -46% | -$28.6M |
|
916
CALL
CRH
CRH
$67.3B
| $37.5M | 0.01% |
300,700
-463,300
| -61% | -$55.2M |
|
917
CALL
BP
BP
$112B
| $37.3M | 0.01% |
1,075,000
+800,000
| +291% | +$28.1M |
|
918
Kite Realty
KRG
$5.26B
| $37.3M | 0.01% |
1,555,883
+287,536
| +23% | +$6.53M |
|
919
PUT
AES
AES
$10.5B
| $37.3M | 0.01% |
2,600,000
-650,000
| -20% | -$9.16M |
|
920
Chord Energy
CHRD
$7.69B
| $37.2M | 0.01% |
401,700
-99,470
| -20% | -$9.22M |
|
921
Assurant
AIZ
$14B
| $36.7M | 0.01% |
152,267
-34,243
| -18% | -$7.65M |
|
922
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.4B
| $36.6M | 0.01% |
76,231
-97,647
| -56% | -$46.2M |
|
923
Fabrinet
FN
$18.9B
| $36.6M | 0.01% |
80,290
-3,864
| -5% | -$1.68M |
|
924
CALL
Goldman Sachs
GS
$301B
| $36.3M | 0.01% |
41,300
-40,400
| -49% | -$33M |
|
925
CALL
Texas Instruments
TXN
$258B
| $36.2M | 0.01% |
208,900
+165,900
| +386% | +$28.4M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.